Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
Kimura M, Tagawa M, Takenaga K, Kondo F, Yamaguchi T, Saisho H, Nakagawara A, Sakiyama S. Kimura M, et al. Cancer Lett. 1998 Jun 5;128(1):47-53. doi: 10.1016/s0304-3835(98)00050-0. Cancer Lett. 1998. PMID: 9652792
Transforming growth factor beta1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotypes in human lung carcinoma cells.
Tada A, Kato H, Takenaga K, Hasegawa S. Tada A, et al. Cancer Lett. 1997 Dec 16;121(1):31-7. doi: 10.1016/s0304-3835(97)00319-4. Cancer Lett. 1997. PMID: 9459171
Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene.
Kimura M, Tagawa M, Takenaga K, Yamaguchi T, Saisho H, Nakagawara A, Sakiyama S. Kimura M, et al. Anticancer Res. 1997 Mar-Apr;17(2A):879-83. Anticancer Res. 1997. PMID: 9137421
Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
Gunji Y, Tagawa M, Matsubara H, Takenaga K, Shimada H, Kondo F, Suzuki T, Nakajima K, Aoki T, Asano T, Ochiai T, Isono K, Kageyama H, Nakamura Y, Sakiyama S. Gunji Y, et al. Int J Cancer. 1996 Mar 28;66(1):135-9. doi: 10.1002/(SICI)1097-0215(19960328)66:1<135::AID-IJC23>3.0.CO;2-B. Int J Cancer. 1996. PMID: 8608957
167 results
Jump to page
Feedback